Replies to post #728259 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

MAA approval then NICE decision the next day.

The donenamab NICE draft guidance you are talking about happened 7 months after the evidence submission on March 19.2024. [That was actually the second version of the submission, do not now when the first was.]

Also note this is not the final decision. They will get public comments to meet again in Jan and a final guidance is expected to be issued in March 26, 2025.

Now, where is NWBO's evidence submission?